Aphios Pharma

Aphios Pharma

Growth Stage

Inspired by Nature, Enabled by Science

Inspired by Nature, Enabled by Science

Overview

Raised this Round: Raised: $48,152

Total Commitments ($USD)

Platform

Netcapital

Start Date

09/06/2018

Close Date

01/31/2019

Min. Goal
$10,000
Max. Goal
$1,070,000
Min. Investment

$99

Security Type

Equity - Common

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$1.00

Pre-Money Valuation

$101,070,000

Year Founded

2018

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Location

Woburn, Massachusetts

Aphios Pharma LLC is exploring how to best leverage, develop, and commercialize cannabis-based drugs for Central Nervous System (CNS) and other disorders. To accomplish this, Aphios Pharma “...utilizes supercritical fluid technologies to improve drug discovery, manufacturing, and formulation in a sustainable, environmentally-friendly manner.” They manufacture pharmaceutical-grade pure natural cannabinoids that both follow cGMP guidelines of the FDA and are in compliance with the Drug Enforcement Agency (DEA). So far, their work has led to endeavors that are likely to advance the science of cannabinoid-based medicines -- as well as make significant contributions to science and medicine.
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Aphios Pharma 07/30/2022 Wefunder $71,000,000 $97,041 SAFE Funded RegCF
Aphios Pharma 01/30/2019 Netcapital $101,070,000 $48,152 Equity - Common Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Aphios Pharma on Netcapital
Platform: Netcapital
Security Type: Equity - Common
Valuation: $101,070,000
Price per Share: $1.00

Follow company

Follow Aphios Pharma on Netcapital

Buy Aphios Pharma's Deal Report

Warning: according to the close date for this deal, Aphios Pharma may no longer be accepting investments.

Aphios Pharma Deal Report

Get KingsCrowd’s comprehensive report on Aphios Pharma including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Aphios Pharma is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Aphios Pharma deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge